Ireland vs Kenya: Access to anti-retroviral drugs, female
Ireland
90.0%
in 2023
Kenya
90.0%
in 2024
Ireland rank
27th
Kenya rank
27th
Access to anti-retroviral drugs, female over time
- Ireland
- Kenya
How they compare
Ireland currently reports 90.0% against 90.0% in Kenya, a difference of 0.0%.
The two have swapped places 4 times across 24 shared years of data; in 2000 it was Ireland ahead.
Ireland ranks 27th and Kenya ranks 27th of 141 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.1% | 6.7% | 56.4% | Ireland |
| 2010s | 76.3% | 63.6% | 12.7% | Ireland |
| 2020s | 88.8% | 86.5% | 2.2% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Ireland or Kenya?
- Ireland, at 90.0% against 90.0% in Kenya as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Ireland and Kenya?
- 0.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and Kenya?
- 24 years are reported by both, from 2000 to 2023.
- How do Ireland and Kenya rank globally for access to anti-retroviral drugs, female?
- Ireland ranks 27th and Kenya ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.